After Hepatitis C Cure, MASLD May Boost Liver Cancer Risk

By News Health
1 hour Ago

(MedPage Today) — WASHINGTON — Liver cancer risk after hepatitis C virus (HCV) cure was significantly greater in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), according to a retrospective cohort study from…

Source link : https://www.medpagetoday.com/meetingcoverage/aasld/118517

Author :

Publish date : 2025-11-13 22:42:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Dads' Valproate Use May Raise Red Flags for Kids' Neurodevelopment

Evidence Linking Processed Foods and Early Colon Cancer Grows

Key HER2-Positive Breast Cancer Therapy Gets Its First Biosimilar

GOP Promised Healthcare Negotiations After the Shutdown, but Dems Are Wary

Medicare's Big Opportunity: Paying for Prevention

Falls Drop Sharply With Lactulose, Tai Chi Combo in Cirrhosis Trial